Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer
Fig 9
Survival analysis involves AR gene. The blue line in the figure indicates the survival of prostate cancer patients whose targets had not changed. Non-blue lines show changes in the survival of prostate cancer patients with changed targets.